Sign in

    Brett Osetec

    Research Analyst at Unaffiliated Analyst

    No publicly available information could be found identifying Brett Osetec as an analyst at Unaffiliated Analyst or documenting professional history, covered companies, performance metrics, credentials, or a LinkedIn profile. As of the most recent search, there are no verifiable details or records supporting the existence of Brett Osetec in this professional context.

    Brett Osetec's questions to GENWORTH FINANCIAL (GNW) leadership

    Brett Osetec's questions to GENWORTH FINANCIAL (GNW) leadership • Q1 2025

    Question

    Brett Osetec of KBW asked for more detail on the potential tailwinds the recently reintroduced WISH Act could provide for Genworth's CareScout offering.

    Answer

    President and CEO Tom McInerney stated that the WISH Act's public-private framework for catastrophic long-term care coverage aligns perfectly with CareScout's strategy. He explained that CareScout's new capped-benefit products are designed to cover the initial period of care, which would be the private responsibility under the act, making private insurance more affordable and viable. The federal government would then cover the high-cost, long-duration claims.

    Ask Fintool Equity Research AI

    Brett Osetec's questions to GENWORTH FINANCIAL (GNW) leadership • Q3 2024

    Question

    Brett Osetec, an analyst, inquired about the potential use of proceeds from the AXA Santander lawsuit and the specifics of the CareScout revenue model.

    Answer

    President and CEO Thomas McInerney stated that proceeds from a favorable lawsuit outcome would prioritize share repurchases, debt reduction, and investment in CareScout. He also detailed the CareScout revenue model, where for every $1,000 in monthly home care savings, CareScout Services earns a $250 fee, with the remaining $750 benefiting GLIC via lower claim costs. CFO Jerome Upton concurred on the use of proceeds.

    Ask Fintool Equity Research AI